BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McColley SA, Ren CL, Schechter MS, Regelmann WE, Pasta DJ, Konstan MW; Epidemiologic Study of Cystic Fibrosis. Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis. Pediatr Pulmonol 2012;47:966-72. [PMID: 22359344 DOI: 10.1002/ppul.22519] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Hritonenko V, Evans DJ, Fleiszig SM. Translocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS. Microbes Infect 2012;14:1366-73. [PMID: 22981600 DOI: 10.1016/j.micinf.2012.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vandevanter DR, Kahle JS, O’sullivan AK, Sikirica S, Hodgkins PS. Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment. Journal of Cystic Fibrosis 2016;15:147-57. [DOI: 10.1016/j.jcf.2015.09.008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
3 Salvatore D, Buzzetti R, Mastella G. An overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease: Cystic Fibrosis Lung Disease in Patient Registries. Pediatr Pulmonol 2016;51:1251-63. [DOI: 10.1002/ppul.23473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
4 Dupuis A, Keenan K, Ooi CY, Dorfman R, Sontag MK, Naehrlich L, Castellani C, Strug LJ, Rommens JM, Gonska T. Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Genet Med 2016;18:333-40. [PMID: 26087176 DOI: 10.1038/gim.2015.79] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
5 Com G, Carroll JL, Castro MM, Tang X, Jambhekar S, Berlinski A. Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis. J Pediatr 2014;164:832-8. [PMID: 24418473 DOI: 10.1016/j.jpeds.2013.11.064] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
6 Filbrun AG, Lahiri T, Ren CL. Clinical Features and Complications of Cystic Fibrosis. Handbook of Cystic Fibrosis. Cham: Springer International Publishing; 2016. pp. 9-41. [DOI: 10.1007/978-3-319-32504-0_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Fayon M, Ladipo Y, Galodé F, Debelleix S, Reix P. Atteinte respiratoire précoce dans la mucoviscidose. Archives de Pédiatrie 2016;23:12S9-12S14. [DOI: 10.1016/s0929-693x(17)30057-x] [Reference Citation Analysis]
8 Galodé F, Ladipo O, Andrieux A, Feghali H, Bui S, Fayon M. Prevalence and Determinants of Wheezing and Bronchodilatation in Children With Cystic Fibrosis: A Retrospective Cohort Study. Front Pediatr 2022;10:856840. [DOI: 10.3389/fped.2022.856840] [Reference Citation Analysis]
9 Heimer SR, Evans DJ, Stern ME, Barbieri JT, Yahr T, Fleiszig SM. Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells. PLoS One 2013;8:e73111. [PMID: 24058462 DOI: 10.1371/journal.pone.0073111] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
10 Konstan MW, Pasta DJ, VanDevanter DR, Wagener JS, Morgan WJ; Scientific Advisory Group and the Investigators and Coordinators of ESCF. Epidemiologic Study of Cystic Fibrosis: 25 years of observational research. Pediatr Pulmonol 2021;56:823-36. [PMID: 33434406 DOI: 10.1002/ppul.25248] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 McColley SA, Martiniano SL, Ren CL, Sontag MK, Rychlik K, Balmert L, Elbert A, Wu R, Farrell PM. Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening. J Cyst Fibros 2022:S1569-1993(22)00628-2. [PMID: 35871976 DOI: 10.1016/j.jcf.2022.07.010] [Reference Citation Analysis]
12 Ren CL, Konstan MW, Rosenfeld M, Pasta DJ, Millar SJ, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Early childhood wheezing is associated with lower lung function in cystic fibrosis. Pediatr Pulmonol 2014;49:745-50. [PMID: 24123917 DOI: 10.1002/ppul.22894] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
13 Mccolley SA, Schechter MS, Morgan WJ, Pasta DJ, Craib ML, Konstan MW. Risk factors for mortality before age 18 years in cystic fibrosis. Pediatr Pulmonol 2017;52:909-15. [DOI: 10.1002/ppul.23715] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
14 Harik NS, Com G, Tang X, Melguizo Castro M, Stemper ME, Carroll JL. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence. Am J Infect Control 2016;44:409-15. [PMID: 26684366 DOI: 10.1016/j.ajic.2015.10.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
15 Korten I, Oestreich MA, Frey U, Moeller A, Jung A, Spinas R, Mueller-Suter D, Trachsel D, Rochat I, Spycher B, Latzin P, Casaulta C, Ramsey K; SCILD, and BILD, study group. Respiratory symptoms do not reflect functional impairment in early CF lung disease. J Cyst Fibros 2021:S1569-1993(21)00116-8. [PMID: 34088612 DOI: 10.1016/j.jcf.2021.04.006] [Reference Citation Analysis]